Phalguni has been writing about the medtech space since 2023 at GlobalData and Drug and Device World, covering everting from AI, robotic surgery, digital therapeutics and femtech. She has written multiple in-depth features and breaking news stories and interviewing C-suite executives across large and small pharma, biotech and medtech companies, and engaging with KOLs in government and regulatory agencies. Phalguni started her career as a physician (MBBS) and medical researcher, specializing in breaking down complex science and new technologies. She has a master’s in healthcare management from University of Kent and a degree in medical statistics from Stanford University. Off work, she loves reading fantasy and light novels.
Latest from Dr. Phalguni Deswal
Boston Scientific-backed company’s PGG therapy limited the growth of abdominal aortic aneurysms, with 90% of AAAs growing more slowly than expected; a Phase II/III trial is ongoing.